|
⚲
|
| Keyboard |
| Ocampo Christine
✚
|
|
|---|---|
| CIK # | 0001280154 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001280154] | |
| 4 | [0001280154] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ocampo Christine | |
| Urovant Sciences Ltd | |
| Tokai Pharmaceuticals Inc | |
| Avanir Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Urovant Sciences Ltd UROV
Common Shares
|
2021-03-29 | Disposed to issuer | 9,810 | ||
|
Urovant Sciences Ltd UROV
Stock Option (Right to Buy) · derivative
|
2021-03-29 | Disposed to issuer | 3,750 | $0.00 | |
|
Urovant Sciences Ltd UROV
Stock Option (Right to Buy) · derivative
|
2021-03-29 | Disposed to issuer | 133,500 | $0.00 | |
|
Urovant Sciences Ltd UROV
Stock Option (Right to Buy) · derivative
|
2021-03-29 | Disposed to issuer | 70,000 | $0.00 | |
|
Urovant Sciences Ltd UROV
Common Shares
|
2021-03-29 | Disposed to issuer | 68,971 | ||
|
Urovant Sciences Ltd UROV
Common Shares
|
2020-05-01 | Grant | 44,346 | $0.00 | |
|
Urovant Sciences Ltd UROV
Common Shares
|
2020-01-07 | Grant | 32,833 | $0.00 | |
|
Urovant Sciences Ltd UROV
Stock Option (Right to Buy) · derivative
|
2019-01-06 | Grant | 70,000 | $0.00 | |
|
Urovant Sciences Ltd UROV
Stock Option (Right to Buy) · derivative
|
2018-10-15 | Grant | 3,750 | $0.00 | |
|
Tokai Pharmaceuticals Inc NVUS
Stock Option (Right to Buy) · derivative
|
2017-05-24 | Grant | 52,500 | $0.00 | |
|
Tokai Pharmaceuticals Inc NVUS
Common Stock
|
2017-05-10 | Buy | 10,010 | $9.99 | 100,000 |
|
Avanir Pharmaceuticals Inc AVNR
Common Stock
|
2014-12-18 | Sell | 5,780 | $16.93 | 97,855 |
|
Avanir Pharmaceuticals Inc AVNR
Common Stock
|
2014-12-16 | Option exercise | 17,500 | $4.18 | 73,150 |
|
Avanir Pharmaceuticals Inc AVNR
Common Stock
|
2014-12-16 | Sell | 17,500 | $16.94 | 296,450 |
|
Avanir Pharmaceuticals Inc AVNR
Common Stock
|
2014-12-16 | Sell | 12,500 | $16.94 | 211,750 |
|
Avanir Pharmaceuticals Inc AVNR
Common Stock
|
2014-12-16 | Option exercise | 12,500 | $2.59 | 32,375 |
|
Avanir Pharmaceuticals Inc AVNR
Stock Option (Right to Buy) · derivative
|
2014-12-16 | Option exercise | 12,500 | $0.00 | |
|
Avanir Pharmaceuticals Inc AVNR
Stock Option (Right to Buy) · derivative
|
2014-12-16 | Option exercise | 17,500 | $0.00 | |
|
Avanir Pharmaceuticals Inc AVNR
Common Stock
|
2014-11-10 | Grant | 19,844 | ||
|
Avanir Pharmaceuticals Inc AVNR
Common Stock
|
2014-11-10 | Grant | 31,992 | ||
| showing 20 of 46 most recent transactions | |||||